Negative regulation of ErbB/EGFR signalling pathways is important for normal development and the prevention of cancer. In a genetic screen to uncover mechanisms that negatively regulate ErbB signalling in Caenorhabditis elegans, we isolated a second-site mutation (sy621) that promotes the activity of a gain-of-function allele (sa62gf) of the let-23 (EGF) receptor tyrosine kinase. We show that activation by the sa62 mutation (C359Y) likely results from a break in the conserved disulphide-bonded eighth module at the junction of CR1 and L2. The sy621 mutation causes a G270E change in the third disulphidebonded module of CR1, and causes no phenotype on its own, but cooperates with the sa62 mutation to promote receptor activity. Although both sa62 single-and doublemutant receptors can function in the absence of ligand, they can be further activated by ligand. Our results support the current model for ligand-induced dimerization based on the recent crystal structures of HER3 and the EGFR, and provide more evidence for the generation of distinctly activated ErbB family members through mutation.
Introduction
The ErbB/EGFR family of receptor tyrosine kinases is involved in cell proliferation and survival, and the control of cell fate during development (Yarden and Sliwkowski, 2001) . Excess signalling by ErbB receptors can lead to abnormal development and contribute to cancer (Yarden, 2001) . We have been using Caenorhabditis elegans vulva development (reviewed in Greenwald, 1997; Sternberg and Han, 1998) to study mechanisms that negatively regulate ErbB signalling. C. elegans has one ErbB family member, LET-23 , and one EGF-like ligand, LIN-3 (Hill and Sternberg, 1992) . There are six vulval precursor cells, P3.p-P8.p, that are competent to respond to . At the end of the second larval stage of development, LIN-3 (EGF) from the anchor cell in the gonad stimulates LET-23 on P6.p to adopt a 11 vulval fate. In parallel, activation of LIN-12/NOTCH, and possibly LET-23, on flanking cells P5.p and P7.p causes them to adopt 21 vulval fates. 11 and 21 vulval fates can be distinguished by their cell division patterns. Due to the proximity of P6.p to the anchor cell, P6.p invariantly adopts a 11 vulval fate, P5.p and P7.p acquire 21 vulval fates, and the other Pn.p cells fuse with the epidermal syncytium hyp7.
Genetic analysis is consistent with a model in which SEM-5 (GRB2) (Clark et al., 1992) -mediated recruitment of LET-341 (SOS) (Chang et al., 2000) to leads to activation of LET-60 (RAS) (Beitel et al., 1990; Han et al., 1990) and SUR-1/MPK-1 (MAP kinase) (Lackner et al., 1994; Wu and Han, 1994) . Many steps in this signalling cascade are negatively regulated. Known inhibitors include SLI-1 (c-CBL) (Yoon et al., 1995) , GAP-1 (Hajnal et al., 1997) , ARK-1 (ACKrelated kinase) , UNC-101 (AP47 medium chain of trans-Golgi AP-1 complexes) (Lee et al., 1994) , and LIP-1 (MAP kinase phosphatase) (Berset et al., 2001) . To further study mechanisms that negatively regulate LET-23 signalling, we performed a genetic screen for mutations that enhance the ability of a gain-of-function allele of let-23 to promote ectopic vulval fates. In addition to isolating extragenic enhancers, we isolated a second-site mutation affecting the LET-23 extracellular domain. The extracellular domains of ErbB family members can be subdivided into four regions termed L1, CR1, L2, and CR2, or I, II, III, and IV (Schlessinger, 2002) . Here, we describe the properties of mutant receptors harbouring changes in the CR1 region.
Results

A new extracellular domain mutation that promotes LET-23 activity
To identify mechanisms that negatively regulate LET-23 signalling, we devised a genetic screen using the gain-offunction let-23(sa62) allele. This allele encodes a receptor with a C359Y change in CR1 of the extracellular domain (Katz et al., 1996) . Most animals harbouring two copies of let-23(sa62gf) display a multivulva phenotype due to the ectopic adoption of vulval fates by P3.p and/or P4.p (Katz et al., 1996) (Table 1) . In contrast, let-23(sa62gf) heterozygotes have mostly wild-type vulval induction (Katz et al., 1996) (Table 1) . We thus used let-23(sa62gf) heterozygotes as a sensitized background in which to identify mutations that promote LET-23 signalling. We mutagenized let-23(sa62gf) heterozygotes with EMS, and looked for F2 progeny that displayed a strong multivulva phenotype and continued to segregate this phenotype. We recovered six alleles, two of which, sy621 and sy608, were dominant enhancers of the let-23(sa62gf)/ þ multivulva phenotype (Table 1) . let-23(sa62gf) homozygotes display the same amount of vulval induction in the presence and absence of the anchor cell, the source of LIN-3 (EGF) for vulva development (Katz et al., 1996) (Table 1) . Thus, the C359Y change causes the receptor to be constitutively active. However, animals that are heterozygous for let-23(sa62gf) require the anchor cell for vulva development (Table 1) , indicating a requirement for ligand under these conditions. To determine if sy621 influences vulval induction by affecting LIN-3 (EGF) production from the anchor cell, we ablated the gonadal primordium, which gives rise to the anchor cell. The presence of the sy621 mutation enhanced receptor activity even in the absence of the anchor cell, indicating that sy621 acts downstream of ligand-binding (Table 1) . However, loss-offunction mutations in either mpk-1 (MAP kinase) or let-341 (SOS) blocked enhancement by sy621, suggesting that sy621 acts upstream of SOS (Table 1) . We determined that sy621 and sy608 were linked to the let-23(sa62gf) mutation, and mapped the mutations to the left and within 65 kbp of the let-23(sa62gf) mutation. We then sequenced let-23 genomic DNA 5 0 of the let-23(sa62gf) mutation from sy621 and sy608 animals, and found that both sy621 and sy608 animals harboured a G to A mutation causing a G270E change in a conserved glycine residue in CR1 (Figure 1 ).
Properties of a receptor harbouring the let-23(sa62gf) mutation
To elucidate the mechanism through which the G270E change promotes LET-23 activity in the background of the C359Y change, we first examined the basic properties of the C359Y change in isolation. Previous work has shown that let-23(sa62gf) heterozygotes do not display the fully penetrant multivulva phenotype of let-23(sa62gf) homozygotes (Katz et al., 1996) (Table 1) . To determine whether C359Y receptor activity is inhibited by wild-type LET-23, we placed one copy of let-23(sa62gf) in trans to either a let-23 null allele, or a chromosome with a deficiency that deletes the entire let-23 gene. These trans heterozygotes do not display the strong multivulva phenotype of let-23(sa62gf) homozygotes, suggesting that a C359Y mutant receptor is not inhibited by wild-type receptor (Table 2) . To confirm this finding, we overexpressed LET-23 from an extrachromosomal array in transgenic animals. On its own, this array confers sufficient expression of LET-23 to fully rescue the viability and vulval defects caused by complete absence of LET-23 (Aroian and Sternberg, 1991; Aroian et al., 1994) (Table 2 ). In let-23(sa62gf) homozygotes, this array did not affect the multivulva phenotype, confirming that the activity of C359Y mutant receptors is not inhibited by wild-type LET-23 (Table 2 ). These data suggest that the constitutive activity of an sa62 mutant receptor is concentrationdependent.
Since let-23(sa62gf) heterozygotes are strongly dependent on the LIN-3 (EGF)-producing anchor cell for vulval induction (Table 1) , we wondered whether besides wild-type receptors, let-23(sa62gf) mutant receptors might also respond to ligand. To directly examine this question, we introduced a transgene in which LIN-3 (EGF) expression is under the control of a heat shockinducible promoter (HS lin-3) into let-23(sa62gf) animals. All six vulval precursor cells (P3.p-P8.p) have the (Katz et al., 1995) . Furthermore, at high LIN-3 (EGF) levels, most of the induced cells adopt 11 vulval fates (Katz et al., 1995) . On its own, let-23(sa62gf) causes on average only four vulval precursor cells to adopt vulval fates, and the induced cells adopt either 11 or 21 fates (Katz et al., 1996) (Table 1 , Figure 2b ). Therefore, the C359Y change caused by the sa62 mutation does not maximally activate the receptor. Heat shock-induced overexpression of LIN-3 (EGF) in let-23(sa62gf) homozygotes caused a greater number of vulval precursor cells to adopt vulval fates (Table 2 ). In addition, most of the induced cells adopted a 11 vulval fate, as evidenced by cell divisions causing descendants to detach from the cuticle (Figure 2d ). Thus, the mutant receptor is still responsive to ligand, and the C359Y change does not activate the receptor by mimicking binding of saturating amounts of ligand. C359 is conserved in all ErbB family members. Previous work in which the analogous cysteine residue in the human EGFR (C305) was changed to tyrosine, found no evidence for constitutive receptor activation (Katz et al., 1996) . Since the C359Y mutant LET-23 displays concentration-dependent activity in worms, it is conceivable that failure to see activation could have resulted from differences in the structures of the human EGFR and LET-23, or from an inability to achieve the correct dose of mutant receptor. We aligned the sequence of the LET-23 extracellular domain with that of the human IGF-1 receptor (IGF-1R), which shares homology in the L1, CR1, and L2 regions, and whose crystal structure has been determined (Garrett et al., 1998) . According to the IGF-1R crystal structure, LET-23 C359 corresponds to C294, which is disulphidebonded to C298 in the eighth disulphide-bonded module of the IGF-1R CR1 (Figure 3a) . Based on this model, we predicted that C359 in LET-23 should be disulphidebonded to C364. This prediction was later supported by alignment of the LET-23 extracellular domain sequence with that of HER3, whose crystal structure has recently been solved (Cho and Leahy, 2002) . LET-23 C359 corresponds to C304 in HER3, which is disulphidebonded to C308, and forms the eighth disulphidebonded module in the CR1 domain ( Figure 3b ). Using a BLAST alignment of LET-23 with HER3, we also obtained a SWISS-MODEL (Peitsch, 1995 (Peitsch, , 1996 Guex and Peitsch, 1997) of the LET-23 extracellular domain ( Figure 3c ). In this model, LET-23 C359 is predicted to be disulphide-bonded to C364, and to form the eighth disulphide-bonded module of CR1. To distinguish between models in which LET-23 C359Y activity results from a broken C359-C364 disulphide bond vs a novel gain-of-function property of Y359, we used site-directed mutagenesis to make a C364G change in LET-23.
We were unable to obtain stable transgenic lines with let-23 transgenes carrying mutations causing either the C359Y or C364G changes in the receptor. We therefore injected animals and examined vulva development in F1 progeny carrying transiently expressed transgenes. To identify transformants, we coinjected the let-23 trans- Figure 1 The sy621 mutation in let-23 changes a conserved glycine to glutamate. Alignment of the third disulphide-bonded module from CR1 in the LET-23 extracellular domain, with the same region in the four mammalian ErbB receptors. Cysteine residues are underlined. The glycine changed by the sy621 mutation is in boldface genes with a plasmid that rescues the lethality caused by a pha-1 mutation. In control experiments with a GFPexpressing plasmid, GFP was coexpressed in 38% of pha-1-rescued animals (n ¼ 440). When coinjected with wild-type let-23, only 2% of pha-1-rescued animals were multivulva (Figure 4a ). In contrast, a let-23 transgene harbouring the sa62 mutation caused an eightfold increase in the frequency of multivulva animals ( Figure 4a) . Similarly, when expressed from a transgene, a C364G mutant receptor caused a 12-fold increase in the frequency of multivulva animals ( Figure 4a ). In view of these data and the crystal structure data, it is likely that in LET-23, C359, and C364 are disulphide-bonded to each other to form the eighth disulphide-bonded module of CR1, and that receptor activation results from loss of this disulphide bond.
Transgenic analysis of the let-23(sy621) mutation
To determine whether the G270E change caused by the let-23(sy621) mutation promotes receptor activation independently of the C359Y change caused by the let-23(sa62gf) mutation, we introduced the sy621 mutation by itself into a let-23 transgene. Unlike transgenes encoding receptors with either the C359Y or C364G changes, a transgene encoding a receptor with the G270E change led to the generation of stable transgenic lines. These transgenic lines showed rescue of the viability, fertility, and vulvaless defects resulting from complete absence of LET-23 (Aroian and Sternberg, 1991; Aroian et al., 1994) (Table 2 ; data not shown). However, the mutant transgene did not cause a multivulva phenotype with greater frequency than wild-type let-23 (Table 2) . Similarly, in a transient transformation assay, a G270E mutant receptor did not induce a greater frequency of multivulva animals than wild-type receptor (Figure 4b) . Thus, the G270E change likely acts by specifically promoting the activity of a receptor carrying a broken C359-C364 disulphide bond.
To verify that the G270E change detected in sy621 and sy608 animals is responsible for the genetic enhancement of the sa62 mutation, we constructed double-mutant transgenes. We generated transgenes in which the G270E change was present with either the C359Y change or the C364G change. As with single mutants breaking the C359-C364 disulphide bond, a double-mutant transgene did not lead to the generation of stable transgenic lines. We therefore used a transient transformation assay to examine the interaction between the two changes. To facilitate our detection of enhancement by the G270E change, we lowered the dose of the injected transgenes so that the single mutations caused a reduced frequency of multivulva animals. Compared to single mutations breaking the C359-C364 disulphide bond, the added presence of the G270E change increased the frequency of the multivulva phenotype by at least a factor of two (Figure 4c ). This effect is consistent with our genetic data, in which the sy621 and sy608 mutations enhance the activity of a single copy of let-23(sa62gf).
Since let-23(sa62) single-mutant receptors can still be activated by ligand, it is possible that the sy621 mutation increases receptor activity such that ligand-induced activation can no longer be achieved. Since vulval induction is already very high in the homozygous double mutant, we used a genetic experiment examining another response to LET-23 signalling to address whether let-23(sy621 sa62gf) mutant receptors respond to ligand. Besides regulating vulva development, the LIN-3/LET-23 pathway is required to promote viability past the L1 larval stage. Null mutants in the LET-23 pathway, including LIN-3 (Ferguson and Horvitz, 1985) , die as L1 larvae. We constructed an F1 strain that was homozygous for let-23(sy621 sa62gf), but heterozygous for a lin-3 null allele that was linked to a recessive dpy-20 loss-of-function mutation. These animals are viable, and are alive either due to the ligandindependent activity of the mutant receptor, or due to the ability to the mutant receptor to respond to the one copy of wild-type lin-3. From an analysis of 53 F2 progeny, we did not detect any homozygous dpy-20 adults, which would have indicated viability in the presence of a homozygous lin-3 null mutant chromo- some. However, we did observe 13 dead L1 animals (25%) in the F2 generation. These data indicate that LET-23 receptor with both the G270E and C359Y changes still responds to ligand, as this response is required for the double-mutant receptor to promote viability.
Discussion
The precise mechanism by which ErbB receptor tyrosine kinases are activated in vivo is not known (reviewed in Yarden and Sliwkowski, 2001; Schlessinger, 2002) . Using a genetic screen in C. elegans with the gain-of- Figure 3 Modelling of the LET-23 extracellular domain predicts that C359 is disulphide-bonded to C364. (a) IGF-1R crystal structure determined to 2.6 Å (Garrett et al., 1998) . LET-23 C359 and C364 correspond to C294 and C298, respectively. (b) HER3 crystal structure determined to 2.6 Å (Cho and Leahy, 2002) . LET-23 C359, C364, and G270 correspond to C304, C308, and G215, respectively. (c) SWISS-MODEL of the LET-23 extracellular domain. C359 is predicted to be disulphide-bonded to C364. (d) EGF/ EGFR cocrystal structure determined to 3.3 Å (Ogiso et al., 2002) . One of the receptor molecules in the dimer and EGF have been left out for clarity. L1, CR1, L2, and CR2 are coloured by yellow, white, purple, and orange, respectively Figure 2d ). The sy621 enhancer mutation causes a G270E change in CR1, which by itself is not activating (Table 2, Figure 4b ). However, in the presence of the C359Y change, the G270E change increases receptor activity (Table 1 , Figure 4c ), while still maintaining responsiveness to ligand. Both the sy621 and sa62 mutations affect residues that are conserved in the mammalian ErbB family members, suggesting a possible general effect on ErbB activity. Previous analysis of the sa62 mutation in the human EGFR (C305Y) did not find evidence for activation by this mutation (Katz et al., 1996) , raising the possibility that in C. elegans, the let-23(sa62gf) phenotype results from a novel property of Y359. Based on the sequence similarity of the LET-23 extracellular domain with that of the IGF-1R and HER3, whose crystal structures have been solved (Garrett et al., 1998; Cho and Leahy, 2002) , we thought that the LET-23 extracellular domain should be structurally similar to that of these other receptors. This notion was supported by a SWISS-MODEL of the LET-23 extracellular domain (Figure 3c ) that was constructed using the HER3 crystal structure as a template (Figure 3b ). After examining all of these receptor structures, we predicted that C359 in LET-23 should be disulphide-bonded to C364 to form the eighth disulphide-bonded module of CR1. In accordance with this prediction, we find that a C364G change in LET-23 phenocopies the C359Y change (Figure 4a ), strongly suggesting that C359 is disulphide-bonded with C364. Thus, LET-23 appears to be activated in vivo by disruption of the eighth disulphide-bonded module, also conserved in the human EGFR (Abe et al., 1998; Garrett et al., 2002) . It is unclear, however, whether differences in experimental conditions, or more subtle differences in the structure of LET-23 account for the different sensitivities of the two receptors to a break in this disulphide bond.
It is likely that dimerization and activation of LET-23 shares some features with its mammalian counterparts. Sequence alignment and the SWISS-MODEL of the LET-23 extracellular domain predict that some deter- Figure 4 Transgenic analysis of LET-23 extracellular domain mutations. Transient transformation assays were performed in let-23(sy17) unc-4(e120)/mnC1; pha-1 animals with pPD118.33 (myo-2:: gfp) (10 ng/ml) and pBX-1 (pha-1) (100 ng/ml). pha-1-rescued F1 animals were examined for vulval induction by Nomarski optics. (a) and (b) Constructs were injected at 25 ng/ml. (c) Constructs were injected at 10 ng/ml Extracellular domain determinants of LET-23 activity N Moghal and PW Sternberg minants of ligand-dependent dimerization of the EGFR are conserved with LET-23. An extension of the CR1 domain that forms the dimerization loop necessary for receptor-receptor interactions (Garrett et al., 2002; Ogiso et al., 2002) appears to be present in LET-23 (Figures 3c,d and 5a ). N247 and N256 (N302 and N311 in LET-23), which are important for loop conformation, are conserved, as well as some of the other amino acids involved in receptor dimerization, including R283 (R339 in LET-23) (Figure 5a ). In the EGFR dimer, Y246 in one molecule has hydrophobic interactions with F230 in the other molecule. In LET-23, reciprocal changes have occurred so that Y246 and F230 have been replaced with F301 and Y285, respectively (Figure 5a ). The EGF domain of LIN-3 shares some features with EGF and TGFa, including identity or similarity of Y37/38, R41/ 42, and L47/48 in and distal to the C loop (W188, R192, and V198, respectively in LIN-3), which is involved in receptor interactions (Figure 5b ). Also, LET-23 may have the acidic amino acid (E395) necessary for contact with LIN-3 R192, and the conserved hydrophobic pocket required to accommodate LIN-3 V198 (Figure 5c ). Studies in tissue culture cells and with recombinant proteins in solution have provided a general framework for how EGFR activation might occur. In the absence of ligand, the EGFR exists in both monomeric and dimeric states, which are thought to have low and high affinity for ligand, respectively (Yarden and Schlessinger, 1987b; Domagala et al., 2000; Sako et al., 2000; Moriki et al., 2001; Yu et al., 2002) . Ligand binding stabilizes the dimerized state and drives activation (Yarden and Schlessinger, 1987a; Sako et al., 2000) . However, dimerization and activation are separable events. Dimerization can be induced without receptor activation, and a mutant form of HB-EGF that cannot induce dimerization can still activate preformed dimers (Yu et al., 2002) . How kinase activity is ultimately increased in dimerized receptors is not understood. There is some evidence for dimerization inducing rotation of the transmembrane domain (Moriki et al., 2001 ), but unlike other protein tyrosine kinases, phosphorylation of a conserved tyrosine residue in the activation loop does not appear to be essential (Gotoh et al., 1992) . Once activated in a dimer, protomers appear to be able to dissociate from each other and ligand, and activate neighbouring apo-receptor molecules in a ligand-independent manner (Verveer et al., 2000) .
The recent successes in solving the crystal structures of the apo-forms of the IGF-1R, EGFR, HER2, and HER3 (Garrett et al., 1998; Cho and Leahy, 2002; Cho et al., 2003; Ferguson et al., 2003) , as well as the ligandbound dimerized form of the EGFR (Garrett et al., 2002; Ogiso et al., 2002) have finally provided the opportunity to understand the details of the structural basis for receptor dimerization. In the apo-forms of HER3 and the EGFR, the ligand-binding domains L1 and L2 are far apart, and the dimerization loop in CR1 is occluded due to intramolecular bonding with CR2 (Cho and Leahy, 2002; Ferguson et al., 2003) (Figure 3b ). However, a fraction of receptor molecules are thought to be in a partially 'closed' conformation in which the dimerization loop-CR2 interactions are disrupted, and L1 and L2 are closer together, generating a receptor state with higher affinity for ligand. Ligand binding is then thought to stabilize this 'closed' conformation, and promote dimerization through sustained exposure of the dimerization loop, and alterations in the positions of other residues in CR1. One way to properly position the L1 and L2 domains for ligand binding and dimerization is to rotate a fixed L1/CR1 body 1301 about an axis close to R310 in the EGFR (Ferguson et al., 2003) . This point of rotation matches the position of the eighth and last disulphide-bonded module in CR1 (C305-C309 in the EGFR) (Abe et al., 1998; Garrett et al., 2002) , which is disrupted by the let-23(sa62gf) mutation. This disulphide-bonded module normally restrains a hinge between CR1 and L2, which if freed, could allow considerable flexibility to the relative positions of CR1 and L2. Thus, the sa62 mutation might increase the frequency with which the LET-23 receptor is in a functionally 'closed' conformation, consisting of a closer positioning of L1 and L2, and proper positioning of the dimerization loop and other determinants for dimerization. These mutant receptors might also be expected to have a higher affinity for ligand. Since let-23(sa62gf) mutant receptors are both constitutively active and responsive to ligand, we favour a model in which the mutation promotes dimerization independently of ligand binding, but still allows stabilization by ligand binding. In support of this model, HER2, which has a constitutively exposed dimerization loop , displays strong concentration-dependent, ligand-independent activity (Di Fiore et al., 1987) , similar to let-23(sa62gf) mutant receptors. LET-23 G270, which is the target of the let-23(sy621) enhancer mutation, is in the third disulphidebonded module of CR1, at the opposite end of C359. According to the SWISS-MODEL of the LET-23 extracellular domain, a G270E change may alter receptor structure by no longer accommodating the side-chain of Y240 located between disulphide-bonded modules 1 and 2 of CR1 (Figure 3c) . If the Y240 sidechain is forced towards L1, the structure or position of L1 might be altered. Thus, a G270E-induced change in L1 might cooperate with a C359Y-induced repositioning of L2 to also promote the 'closed' conformation and greater accessibility of the dimerization loop and/or other determinants necessary for dimerization.
Finally, it also is possible that the C359Y and G270E changes promote receptor activation through a different mechanism. Two mutations in the human EGFR indicate that there are multiple ways in which ErbB receptors can be activated through perturbation of the extracellular domain. In glioblastomas, rearrangements of the EGFR gene that delete exons 2-7 (amino acids 6-273) (Wong et al., 1992) , result in constitutively dimerized and activated receptors (Huang et al., 1997) . Since this deletion removes the loop required for ligandinduced dimerization, other determinants must drive dimerization in its absence, such as those found in the transmembrane domain (Tanner and Kyte, 1999; Mendrola et al., 2002) . Also, mutation of an N-linked glycosylation site in L2, N420, results in constitutive dimerization and activation of the EGFR, but prevents ligand binding (Tsuda et al., 2000) . This latter type of activation is different from that observed in LET-23 with the C359Y/C364G and G270E changes, since even the double mutant LET-23 can still respond to ligand. It thus appears to be possible to generate multiple distinctly activated ErbB receptor states through mutation.
Materials and methods
Strains and mutagenesis
C. elegans were cultured at 201C (Brenner, 1974) . Alleles used were: dpy-2(e8), unc-104(e1265), let-23(sa62gf) (Katz et al., 1996) , let-23(sy17) (Aroian and Sternberg, 1991) , unc-4(e120), rol-1(e91) on LGII; pha-1(e2123ts) (Granato et al., 1994) , mpk-1(ku1) (Wu and Han, 1994 ) on LGIII; lin-3(n1059) (Ferguson and Horvitz, 1985) , dpy-20(e1282) on LGIV; let-341(ku231) (Chang et al., 2000) on LGV; syIs1 (Katz et al., 1995) on LGX. Genetic balancers and deficiencies used were: mnC1 [dpy-10(e128) unc-52(e444)] and mnDf63 on LGII. All let-23(sa62gf) strains carried the linked mutation unc-4(e120), and heterozygous let-23(sa62gf)/ þ strains were balanced with mnC1. let-23(sa62gf) unc-4/mnC1 animals were mutagenized with ethylmethanesulphonate (Brenner, 1974) . A total of 23 000 haploid genomes were screened. Non-Unc F2 animals displaying a strong multivulva (Muv) phenotype were picked, and animals continuing to segregate a highly penetrant Muv phenotype were saved.
Mapping and sequencing
Mapping was initially performed using F1 s of the genotype sy621 let-23(sa62gf) unc-4/dpy-2 rol-1. Two Dpy-Muv-Unc non-Rol recombinants picked up sy621 and one did not, placing sy621 to the right of dpy-2 and to the left of let-23. Using F1 s of the genotype dpy-2 sy621 let-23(sa62gf) unc-4/ unc-104, three unc-104 let-23(sa62gf) unc-4 recombinants were obtained, all of which picked up sy621, placing sy621 to the right of unc-104. Using unc-104 sy621 let-23(sa62gf) unc-4 and CB4856, a Hawaiian isolate of C. elegans, 12 recombinants were obtained that had lost unc-104, but retained sy621. Analysis of CB4856 single nucleotide polymorphisms placed sy621 to the right of cosmid T24H10. let-23 genomic DNA including and 5 0 of the sa62 mutation was amplified by PCR from sy621 let-23(sa62gf) and sy608 let-23(sa62gf) homozygotes and directly sequenced.
Transgenes and microinjection
All let-23 constructs were derived from pk7-13.8 , which contains a full-length genomic clone of let-23 in pBS (Stratagene); this clone rescues all of the let-23 mutant phenotypes (Lesa and Sternberg, 1997) . pk7-sy621, which introduces a G270E change into LET-23 was constructed by overlap extension PCR using the primer sets, ZK1067-7 5 0 -ttc agt cta cta ctc tct gtc ccg-3 0 and sy621-2 5 0 -cc gtg acc tgt aca ttc tcc aag aca agc cga gtc ac-3 0 ; and ZK1067-8 5 0 -a aat tct caa aga tta tac gat gat ctc-3 0 and sy621-1 5 0 -gt gac tcg gct tgt ctt gga gaa tgt aca ggt cac gg-3 0 . pk7-sy621 sa62 was constructed by subcloning a let-23 fragment harboring the sy621 mutation into pk7-sa62 (Katz et al., 1996) . pk7-C364G was constructed by site-directed mutagenesis using Expand Long (Roche) and the primers ZK1067-9 5 0 -g tgt gaa aaa tgc aga agt tcc agc gga cca aaa agt acg ttt tc-3 0 and ZK1067-10 5 0 -ga aaa cgt act ttt tgg tcc gct gga act tct gca ttt ttc aca c-3 0 , which change the C364 codon to G364. pk7-sy621 C364G was constructed by subcloning a let-23 fragment carrying the sy621 mutation into pk7-C364G. Mutations were confirmed by DNA sequencing.
The extrachromosomal arrays syEx569 [let-23(wt)] and syEx568 [let-23(sy621)] were obtained by injecting a mixture of pPD118.33 (myo-2:: gfp) (10 ng/ml), pBX-1 (pha-1) (Granato et al., 1994) (100 ng/ml), and either pk7-13.8 (50 ng/ml) or pk7-sy621 (50 ng/ml), respectively, into let-23(sy17) unc-4/mnC1; pha-1 animals. The extrachromosomal array syEx567 [HS lin-3], which contains lin-3 under the control of an inducible heat shock promoter, was generated by injection of pRH51 (lin-3) (Katz et al., 1995) (50 ng/ml), pPD118.33 (myo-2:: gfp) (10 ng/ ml), and pBSKS (Stratagene) (90 ng/ml).
Vulval induction and gonad ablations
Vulval development was scored during the L4 stage under Nomarski optics (Sternberg and Horvitz, 1986) . The number of vulval nuclei is used to extrapolate how many of the Pn.p cells were induced to adopt vulval fates. A vulval precursor cell (VPC) that gives rise to seven or eight great granddaughters and no hyp7 tissue is scored as 1.0 cell induction. A VPC in which one daughter fuses with hyp7, and the other daughter divides to generate three or four great granddaughter cells is scored as 0.5 cell induction. In wild-type animals, P5.p, P6.p, and P7.p each undergo 1.0 cell induction, whereas the other Pn.p cells do not adopt vulval fates, resulting in a total of 3.0 cell induction. Animals displaying more than 3.0 cell induction are multivulva and animals with less than 3.0 cell induction are vulvaless. Gonad cells (Z1, Z2, Z3, and Z4) were ablated with a laser microbeam during the L1 stage (Bargmann and Avery, 1995) .
SWISS-MODEL
The LET-23 extracellular domain was modelled using the crystal structure of HER3 (1M6BB.pdb) and the optimize mode of SWISS-MODEL (Peitsch, 1995 (Peitsch, , 1996 Guex and Peitsch, 1997) , an internet based automated comparative protein modelling server (http://www.expasy.ch/swissmod/ SWISS-MODEL.html). In the optimize mode, the LET-23 extracellular domain sequence was aligned with that of HER3 using a BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) alignment. The quality of the model was evaluated in a WhatCheck report created by the WHAT IF program (Vriend, 1990; Hooft et al., 1996) . Structure Z-scores included first-generation packing quality, À3.006; second-generation packing quality, À5.392; Ramachandran plot appearance, À2.550; chi-1/chi-2 rotamer normality, À0.079; and backbone conformation, À3.369. RMS Z-scores included bond lengths, 1.312; bond angles, 1.325; omega angle restraints, 1.498; side chain planarity, 1.975; improper dihedral distribution, 1.523; and inside/outside distribution, 1.103.
